Lori Patnaude

609 total citations
13 papers, 412 citations indexed

About

Lori Patnaude is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lori Patnaude has authored 13 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Genetics. Recurrent topics in Lori Patnaude's work include Digestive system and related health (4 papers), Sphingolipid Metabolism and Signaling (3 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (2 papers). Lori Patnaude is often cited by papers focused on Digestive system and related health (4 papers), Sphingolipid Metabolism and Signaling (3 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (2 papers). Lori Patnaude collaborates with scholars based in United States, Germany and France. Lori Patnaude's co-authors include Louise K. Modis, Xiaoming Wu, Sarah S. Wilson, Heather Knight, Robert W. Dunstan, Sonia Terrillon, Lucy Phillips, Susan Lukas, Ryan M. Fryer and Joshua C. Horan and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Lori Patnaude

13 papers receiving 404 citations

Peers

Countries citing papers authored by Lori Patnaude

Since Specialization

Citations

This map shows the geographic impact of Lori Patnaude's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Patnaude with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Patnaude more than expected).

Fields of papers citing papers by Lori Patnaude

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Patnaude. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Patnaude. The network helps show where Lori Patnaude may publish in the future.

Co-authorship network of co-authors of Lori Patnaude

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Patnaude. A scholar is included among the top collaborators of Lori Patnaude based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Patnaude. Lori Patnaude is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Optimized Culture Conditions for Improved Growth and Functional Differentiation of Mouse and Human Colon Organoids 2021 ·Frontiers in Immunology ·Sarah S. Wilson, (unknown), (unknown), Heather Knight, Lori Patnaude, Xiaoming Wu, Lucy Phillips, Susan V. Westmoreland, Robert W. Dunstan, Edda Fiebiger, Sonia Terrillon	44
2	Mechanisms and regulation of IL-22-mediated intestinal epithelial homeostasis and repair 2021 ·Life Sciences ·Lori Patnaude, (unknown), (unknown), Xiaoming Wu, Heather Knight, (unknown), Sarah S. Wilson, Valerie Pivorunas, József Kármán, Lucy Phillips, Robert W. Dunstan, Rajesh V. Kamath, Bradford L. McRae, Sonia Terrillon	77
3	P93 - Tissue stem cell derived human intestinal organoids: A novel and physiologically relevant model to evaluate cytochrome P450 induction in gut 2020 ·Drug Metabolism and Pharmacokinetics ·David M. Stresser, Jun Sun, Lori Patnaude, Sonia Terrillon, Sarah S. Wilson	1
4	P067 Advancing IL-22-Based Therapies for Inflammatory Bowel Diseases With Human Intestinal Organoids 2019 ·The American Journal of Gastroenterology ·Lori Patnaude, (unknown), (unknown), Sarah S. Wilson, Heather Knight, (unknown), (unknown), (unknown), (unknown), Valerie Pivorunas, Susan V. Westmoreland, (unknown), Annette Schwartz, (unknown), Bradford L. McRae, Sonia Terrillon	1
5	158 – Leveraging Human Intestinal Organoids to Advance Il-22-Based Therapies for Ulcerative Colitis 2019 ·Gastroenterology ·Lori Patnaude, (unknown), (unknown), Sarah S. Wilson, (unknown), Heather Knight, (unknown), (unknown), (unknown), (unknown), (unknown), Valerie Pivorunas, Susan V. Westmoreland, Robert W. Dunstan, (unknown), Anthony Slavin, Rajesh V. Kamath, Bradford L. McRae, Sonia Terrillon	2
6	A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo 2014 ·PLoS ONE ·Nuruddeen D. Lewis, Lori Patnaude, Josephine Pelletier, Donald Souza, Susan Lukas, Jim King, Jonathan D. Hill, (unknown), Kelli R. Ryan, Sudha Desai, Donna Skow, Stefan G. Kauschke, Andre Broermann, Daniel Kuzmich, Christian Harcken, Eugene R. Hickey, Louise K. Modis	54
7	G Protein–Coupled Bile Acid Receptor 1 Stimulation Mediates Arterial Vasodilation through a KCa1.1 (BKCa)–Dependent Mechanism 2014 ·Journal of Pharmacology and Experimental Therapeutics ·Ryan M. Fryer, (unknown), (unknown), Lori Patnaude, Donna Skow, (unknown), (unknown), (unknown), Daniel Kuzmich, John Lord, Sulagna Sanyal, Hui Yu, Christian Harcken, Matthew A. Cerny, Eugene R. Hickey, (unknown)	39
8	No Differences Observed among Multiple Clinical S1P1 Receptor Agonists (Functional Antagonists) in S1P1 Receptor Down-regulation and Degradation 2013 ·SLAS DISCOVERY ·Susan Lukas, Lori Patnaude, Sokol Haxhinasto, Anthony Slavin, (unknown), (unknown), Louise K. Modis	13
9	Circulating Monocytes Are Reduced by Sphingosine-1-Phosphate Receptor Modulators Independently of S1P3 2013 ·The Journal of Immunology ·Nuruddeen D. Lewis, Sokol Haxhinasto, Shawn Anderson, (unknown), (unknown), (unknown), Sudha Desai, Lori Patnaude, Susan Lukas, Kelli R. Ryan, Anthony Slavin, Maryanne L. Brown, Louise K. Modis	54
10	The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat 2012 ·PLoS ONE ·Ryan M. Fryer, (unknown), Paul C. Harrison, (unknown), (unknown), (unknown), (unknown), Joshua C. Horan, Lori Patnaude, Louise K. Modis, Glenn A. Reinhart	72
11	Assay Optimization: A Statistical Design of Experiments Approach 2007 ·Clinics in Laboratory Medicine ·(unknown), Carol Homon, Mohammed A. Kashem, Stephen W. Mason, Richard M. Nelson, Lori Patnaude, Jeffrey D. Yingling, Paul B. Taylor	37
12	Development of a High-Throughput Assay to Measure Histidine Decarboxylase Activity 2006 ·SLAS DISCOVERY ·Elias August, Lori Patnaude, Jerry L. Hopkins, Joey Studts, (unknown), (unknown), (unknown), Martha Brown, Alisa K. Kabcenell, Daniel Rajotte	4
13	Assay Optimization: A Statistical Design of Experiments Approach 2006 ·JALA Journal of the Association for Laboratory Automation ·(unknown), Carol Homon, Mohammed A. Kashem, Stephen W. Mason, Richard M. Nelson, Lori Patnaude, Jeffrey D. Yingling, Paul B. Taylor	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact